These findings suggest that OGA inhibition can modulate enzymatic imbalance in OGT-CDG mice possessing microcephaly and motor deficits and that blood can be used to monitor the effects of interventions targeting O-GlcNAc dyshomeostasis. Here, OGT is linked to microcephaly.